One BioMed Pte
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $4.7M
Investors
- 4
About One BioMed Pte
One BioMed Pte Ltd specializes in advanced molecular solutions, offering innovative technologies for automated nucleic acid extraction.Founded in 2015 in Singapore, One BioMed Pte Ltd focuses on developing automated molecular platforms. The company was established by Mi-Kyoung Park, who has a history of entrepreneurial endeavors.One BioMed's primary offering is the integrated Xceler8™ Solution, a state-of-the-art molecular platform designed for automated nucleic acid extraction and purification. This innovative technology employs a patented reversible-crosslinking method, allowing for efficient and selective capture and release of nucleic acids from various biological samples. The Xceler8 Solution is geared towards both research and clinical applications, enabling biomedical researchers and clinicians to perform advanced nucleic acid extraction with minimal manual intervention. By providing a truly walk-away solution, One BioMed addresses the increasing demand for high-throughput molecular testing across diverse fields, including genomics and diagnostics.40 for the same year. Specific regions for growth include further penetration within Asia and Europe, with plans to establish a stronger presence by 2023.
Who invested in One BioMed Pte
4 investors across 1 round
See all investors in One BioMed Pte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 30, 2020
Amount
$4.7M
Investors
Questions about One BioMed Pte
Who invested in One BioMed Pte?
One BioMed Pte has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has One BioMed Pte raised?
One BioMed Pte has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did One BioMed Pte last raise money?
One BioMed Pte's most recent round on record is a Series A, in Dec 2020.
What does One BioMed Pte do?
One BioMed Pte Ltd specializes in advanced molecular solutions, offering innovative technologies for automated nucleic acid extraction.
Where is One BioMed Pte headquartered?
One BioMed Pte is headquartered in Singapore, Singapore.
Which VCs invest in companies like One BioMed Pte?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at One BioMed Pte's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like One BioMed Pte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.